Drug Type Small molecule drug |
Synonyms Sabarubicin, BMS 195615, BMS-195615 + [1] |
Target |
Mechanism Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Molecular FormulaC32H38ClNO13 |
InChIKeyBSRQHWFOFMAZRL-BODGVHBXSA-N |
CAS Registry169317-77-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Sabarubicin Hydrochloride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Phase 2 | BE | 01 Aug 2001 | |
Castration-Resistant Prostatic Cancer | Phase 2 | FR | 01 Aug 2001 | |
Castration-Resistant Prostatic Cancer | Phase 2 | DE | 01 Aug 2001 | |
Castration-Resistant Prostatic Cancer | Phase 2 | IL | 01 Aug 2001 | |
Castration-Resistant Prostatic Cancer | Phase 2 | ES | 01 Aug 2001 | |
Castration-Resistant Prostatic Cancer | Phase 2 | CH | 01 Aug 2001 | |
Recurrent Lung Small Cell Carcinoma | Phase 1 | CN | 30 Dec 2014 | |
Recurrent Lung Small Cell Carcinoma | Phase 1 | CN | 30 Dec 2014 | |
Refractory Small Cell Lung Carcinoma | Phase 1 | CN | 30 Dec 2014 | |
Refractory Small Cell Lung Carcinoma | Phase 1 | CN | 30 Dec 2014 |
Phase 1/2 | Extensive stage Small Cell Lung Cancer First line | - | cjuffsosml(uxcwjcegdo) = edntpovrna enixbumqxg (rrvrdlrmgn ) View more | - | 20 May 2010 | ||
Phase 2 | 26 | xviiwmzlwh(iryvhcnces) = eydbmlyknl jqwadeqpba (lbmuqylhtz, 22.43 - 57.46) View more | - | 20 May 2008 |